IMPACT of AspireSR® for VNS Therapy on Healthcare Resource Utilisation and Clinical Outcomes.

NCT05975931 · clinicaltrials.gov ↗
TERMINATED
Status
15
Enrollment
INDUSTRY
Sponsor class

Stopped The decision to terminate was taken based on study team capacity not sufficient and alignment with the sponsor.

Conditions

Sponsor

LivaNova

Collaborators